Epitalon vs Vilon: Comparing Two Khavinson Bioregulator…

For laboratory and research use only. Not for human consumption.

Epitalon and Vilon are both products of the same Russian bioregulator peptide research program, but they are frequently confused with each other or treated as interchangeable simply because they share a research lineage. They are not interchangeable — they differ in chain length, sequence, and the specific tissue systems each has been studied in. This comparison lays out the structural distinctions and what the published research literature has actually examined for each.

Key Facts

Epitalon is a synthetic tetrapeptide: Ala-Glu-Asp-Gly (AEDG).
Vilon is a synthetic dipeptide: Lys-Glu (KE).
Both originate from the bioregulator peptide research program associated with Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology.
Epitalon research literature has focused substantially on cell-culture studies of telomerase activity and gene expression markers.
Vilon research literature has focused substantially on thymus-associated tissue and immune-related markers in animal models.

Two Peptides, One Research Lineage: The Khavinson Bioregulator Program

Both Epitalon and Vilon emerge from decades of Russian peptide bioregulator research associated with Vladimir Khavinson and colleagues. The underlying research proposition behind this class of short synthetic peptides is that very short amino acid sequences — as brief as two to four residues — can be studied for tissue-specific gene expression effects in model systems, with different short peptides proposed to correspond to different tissue types. Epitalon and Vilon are two of the more frequently referenced compounds to come out of that program, but they were designed and studied in relation to different tissues.

Structural Comparison: Tetrapeptide vs Dipeptide

The most immediate difference between the two is chain length. Epitalon is a tetrapeptide — four amino acid residues in the sequence Ala-Glu-Asp-Gly. Vilon is a dipeptide — just two residues, Lys-Glu. This is not a trivial distinction: chain length affects a peptide's overall molecular weight, its three-dimensional conformational freedom, and the range of ways it can interact with binding targets in a research setting. A four-residue peptide has more structural information encoded in its sequence than a two-residue peptide, which is part of why these two compounds have been studied in different research contexts rather than treated as substitutes for one another.

Epitalon in the Research Literature

Epitalon has been described in the literature as a synthetic analog related to naturally derived pineal peptide preparations studied earlier in the same research program. Published research on Epitalon includes cell culture studies examining telomerase enzyme activity and gene expression markers, alongside animal-model studies referenced throughout the bioregulator literature. Our Epitalon research and longevity literature overview summarizes these published findings in more depth, including the specific model systems used.

Vilon in the Research Literature

Vilon's published research has centered on a different tissue system: the literature associates Vilon most closely with studies of thymus-related tissue and markers connected to immune cell populations in animal models. As a dipeptide, Vilon has also been used in some of the program's foundational work exploring how short peptide sequences might correspond to gene expression regulation in specific tissue types. Our Vilon research overview covers what has been published and in which model systems.

How Researchers Distinguish the Two in Study Design

Because Epitalon and Vilon are structurally distinct and have been studied for different tissue-specific research questions, treating them as interchangeable in a study design would conflate two different compounds with two different sequence lengths and two different bodies of published literature behind them. A researcher deciding between the two should be looking at which specific tissue system or research question the study is designed around, not just which compound is more commonly referenced in the bioregulator peptide category generally.

Where These Compounds Fit in the Peptide Research Timeline

Both Epitalon and Vilon sit within a much longer history of synthetic peptide research. Our peptide research timeline, 1921 to 2026, traces that broader arc — from early peptide chemistry through the Khavinson bioregulator program and into the current landscape of research-grade synthetic peptides available for laboratory study. Researchers interested in either compound, or in the wider bioregulator peptide category, can browse the current catalog in our shop.

Frequently Asked Questions

What is the structural difference between Epitalon and Vilon?

Epitalon is a synthetic tetrapeptide with the sequence Ala-Glu-Asp-Gly (AEDG), while Vilon is a synthetic dipeptide with the sequence Lys-Glu (KE). Both are short-chain bioregulator peptides developed within the same research lineage, but they differ in chain length, amino acid composition, and the tissue-specific research contexts in which each has been studied.

Who developed Epitalon and Vilon, and why are they studied together?

Both peptides originate from the bioregulator peptide research program led by Vladimir Khavinson and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology. They are studied together because they belong to the same class of short synthetic peptides proposed to interact with tissue-specific gene expression, even though each has been investigated in different model systems and for different tissue targets.

What has Epitalon been studied for in laboratory research?

Laboratory research on Epitalon has examined its effects in cell culture models, including studies looking at telomerase enzyme activity and markers of cellular gene expression, as well as animal-model studies referenced in the bioregulator peptide literature. Our Epitalon research literature overview reviews these findings in more detail.

What has Vilon been studied for in laboratory research?

Vilon has primarily been studied in the bioregulator literature in relation to thymus-associated tissue and immune-related gene expression markers in animal models. Our Vilon research overview summarizes the published findings.

Where do Epitalon and Vilon fit in the broader history of peptide research?

Both compounds are part of a longer arc of synthetic peptide research that spans from early 20th-century peptide chemistry through the Khavinson bioregulator program and into the modern research-peptide landscape. Our peptide research timeline traces that history from 1921 to 2026.